Seer Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $2.56
- Today's High:
- $2.65
- Open Price:
- $2.59
- 52W Low:
- $2.32
- 52W High:
- $9.8
- Prev. Close:
- $2.59
- Volume:
- 266847
Company Statistics
- Market Cap.:
- $170.08 million
- Book Value:
- 6.54
- Revenue TTM:
- $16.62 million
- Operating Margin TTM:
- -634.19%
- Gross Profit TTM:
- $7.09 million
- Profit Margin:
- 0%
- Return on Assets TTM:
- -13.48%
- Return on Equity TTM:
- -21.1%
Company Profile
Seer Inc had its IPO on 2020-12-04 under the ticker symbol SEER.
The company operates in the Healthcare sector and Biotechnology industry. Seer Inc has a staff strength of 164 employees.
Stock update
Shares of Seer Inc opened at $2.59 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $2.56 - $2.65, and closed at $2.57.
This is a -0.77% slip from the previous day's closing price.
A total volume of 266,847 shares were traded at the close of the day’s session.
In the last one week, shares of Seer Inc have slipped by -5.51%.
Seer Inc's Key Ratios
Seer Inc has a market cap of $170.08 million, indicating a price to book ratio of 0.8539 and a price to sales ratio of 28.3714.
In the last 12-months Seer Inc’s revenue was $16.62 million with a gross profit of $7.09 million and an EBITDA of $-100683000. The EBITDA ratio measures Seer Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Seer Inc’s operating margin was -634.19% while its return on assets stood at -13.48% with a return of equity of -21.1%.
In Q2, Seer Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 10.7%.
Seer Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-1.56 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Seer Inc’s profitability.
Seer Inc stock is trading at a EV to sales ratio of 0.1123 and a EV to EBITDA ratio of 0.1742. Its price to sales ratio in the trailing 12-months stood at 28.3714.
Seer Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $461.20 million
- Total Liabilities
- $15.81 million
- Operating Cash Flow
- $22.94 million
- Capital Expenditure
- $1.15 million
- Dividend Payout Ratio
- 0%
Seer Inc ended 2024 with $461.20 million in total assets and $0 in total liabilities. Its intangible assets were valued at $461.20 million while shareholder equity stood at $418.12 million.
Seer Inc ended 2024 with $0 in deferred long-term liabilities, $15.81 million in other current liabilities, 1000.00 in common stock, $-266886000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $56.40 million and cash and short-term investments were $320.21 million. The company’s total short-term debt was $2,249,000 while long-term debt stood at $0.
Seer Inc’s total current assets stands at $335.38 million while long-term investments were $75.81 million and short-term investments were $263.81 million. Its net receivables were $6.30 million compared to accounts payable of $5.25 million and inventory worth $5.26 million.
In 2024, Seer Inc's operating cash flow was $22.94 million while its capital expenditure stood at $1.15 million.
Comparatively, Seer Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $2.57
- 52-Week High
- $9.8
- 52-Week Low
- $2.32
- Analyst Target Price
- $6.67
Seer Inc stock is currently trading at $2.57 per share. It touched a 52-week high of $9.8 and a 52-week low of $9.8. Analysts tracking the stock have a 12-month average target price of $6.67.
Its 50-day moving average was $3.76 and 200-day moving average was $4.37 The short ratio stood at 6.17 indicating a short percent outstanding of 0%.
Around 585.1% of the company’s stock are held by insiders while 7971.2% are held by institutions.
Frequently Asked Questions About Seer Inc
Similar Industry Stocks (Biotechnology)
Most Active
Top Gainers
Top Losers
About
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. Seer, Inc. has a collaboration agreement with Oregon Health & Science University; The Broad Institute of MIT and Harvard; Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.